← Open Payments lookup

JOSIE WEBER: Open Payments

NPI 1073240115 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$658 in 41 payments from 15 companies in 2025. Trend: 2023 $419 · 2024 $697 · 2025 $658

Food & beverage: $587Education: $71
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.17$193
Otsuka America Pharmaceutical, Inc.4$85
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$53
E.R. Squibb & Sons, L.L.C.3$45
Teva Pharmaceuticals USA, Inc.2$44
ABBVIE INC.2$42
Neurocrine BioSciences, Inc.2$38
Indivior Inc.2$32
Janssen Pharmaceuticals, Inc1$25
Collegium Pharmaceutical, Inc.1$23

Products named: FANAPT, REXULTI, CAPLYTA, COBENFY, AUSTEDO XR, VRAYLAR, INGREZZA, SUBLOCADE.

Industry payments across IN — which companies pay providers there.